相关实验视频

Updated: Jul 16, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

ExoPD-L1:瘤进展的助手和潜在的诊断标志物

Rong Hu^1,2, Md Shoykot Jahan^1,2, Lijun Tang^1,2

¹School of Life Sciences, Central South University, Changsha, China.

Frontiers in oncology

|September 22, 2023

概括

在外体上编程的细胞死亡配体1 (PD-L1) 可以抑制免疫反应,阻碍癌症治疗. 向外体PD-L1为有效的癌症治疗提供了一个有希望的策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

编程细胞死亡1 (PD-L1) 结合编程细胞死亡1 (PD-1) 抑制免疫细胞功能,使癌症治疗复杂化.
外体,小的细胞外囊泡,运输分子,如PD-L1,促进细胞间的通信.
携带PD-L1的瘤衍生外体 (TEX) 有助于免疫抑制性瘤微环境.

研究的目的:

审查外体PD-L1 (ExoPD-L1) 的免疫抑制作用.
讨论调节 ExoPD-L1.1. 的因素.
探索用于ExoPD-L1量化和检测的新兴方法.
突出在癌症治疗中针对 ExoPD-L1 的潜力.

主要方法:

文献综述侧重于癌症中的外体PD-L1.
对PD-L1通过外生体传输的研究进行分析.
检查当前的检测和量化技术,以 ExoPD-L1.1.
讨论涉及ExoPD-L1.1.的治疗策略.

主要成果:

外体PD-L1在癌症中起着重要的免疫抑制作用.
外基因组作为PD-L1的载体,调解细胞间通信和免疫逃避.
检测和量化ExoPD-L1的各种方法正在出现.
准ExoPD-L1是一个新的治疗途径.

结论:

外体PD-L1是瘤免疫逃避的一个关键因素.
针对ExoPD-L1,可能用于组合疗法,有望改善癌症治疗结果.
进一步研究ExoPD-L1调节和检测是有必要的.

关键词:

在 ExoPD-L1 中使用.在 ExoPD-L1 的量化过程中,组合疗法治疗组合治疗.免疫抑制是一种免疫抑制.监管因素监管因素

更多相关视频

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...